FAM171A2 and Parkinson disease: The therapeutic target FAM171A2, newly discovered by the team of Yu Jintai from Huashan Hospital Affiliated to Fudan University, and the PD PET molecular imaging biomarker developed by Renmin Hospital of Wuhan University have shown high potential value in the early diagnosis and treatment intervention of PD.